Set out to make a difference

MetaCure’s board is composed of international medical device and finance executives as well as leading researchers in the field of diabetes.

Prof. Shlomo Ben-Haim, MD, D.Sc – Chairman and Founder

Professor Shlomo Ben-Haim, a renowned medical device entrepreneur, has an impressive record of co-founding companies and maximizing their value. He has held faculty appointments as a Professor of Medicine, Physiology and Biophysics at both Harvard University and the Technion – Israel Institute of Technology. Professor Ben-Haim’s education is in Medicine and Biophysics. He has published over 200 scientific papers in peer-reviewed journals, and is the recipient of a long list of prizes for his research and inventions. Professor Ben-Haim is the inventor of over 550 patents and patent applications worldwide, including those for a navigated cardiac catheterization system and an implantable device for treating congestive heart failure and diabetes. Professor Ben-Haim is now focusing on building businesses in healthcare that improve patient health, and reduce total healthcare spending.

Prof. Harold Lebovitz, MD, FACE

Professor Lebovitz has previously served as Chief of the Section of Endocrinology and Diabetes, and Director of the National Institutes of Health (NIH)-sponsored Clinical Research Center at the State University of New York Health Science Center, where he currently serves as a Professor. He also currently serves on the Board of Directors of the American Association of Clinical Endocrinologists (AACE). He is an internationally recognized authority in the field of diabetes and is author or co-author of more than 200 peer-reviewed publications and 100 chapters or books. Dr. Lebovitz received his BSc and MD from the University of Pittsburgh.

Simos Kedikoglou, MD, CFA, MBA

Dr. Simos Kedikoglou is a board member at MetaCure, and is the CEO of Impulse Dynamics since 2013. He was previously a Corporate Vice President of Business Development for Boston Scientific with responsibility for acquisitions, licensing and distribution deals in the US, Europe and Asia. Prior to Boston Scientific, Simos was an Associate Partner with McKinsey & Company in the US, focusing on acquisitions in pharmaceutical and medical devices Simos holds a Medical Degree from the University of Athens, Greece, an MBA with distinction and a Master’s in Public Health from Harvard University, and he is a CFA Charterholder.

James Keyes, MA

James Keyes is a Bermuda resident and citizen. He was a partner for Appleby, the offshore law firm, for eleven years until he retired from the firm in 2008. He joined Appleby in 1993 and was team leader of the Funds & Investment Services Team. Prior to Appleby, he was employed in the Corporate Department of Freshfields law firm, and worked in London, New York and Hong Kong offices. Mr. Keyes attended Oxford University in England as a Rhodes Scholar and graduated with a degree in Politics, Philosophy and Economics (M.A. with Honours) in 1985. He was admitted as a non-executive director of a number of funds and companies. He is also managing director of Renaissance Capital, the emerging markets investment group. He became a Notary Public in 1988.

Antony Owers, FCA

Mr. Owers has been with MetaCure since its formation. He was with the accounting firm KPMG from 1969-98 in London, São Paulo, Brazil and Curaçao, the latter as a Senior Partner for many years. He has been a Fellow of the Institute of Chartered Accountants in England and Wales since 1980, and has been British consul to the Dutch Caribbean islands since 1997. He is also treasurer of many charitable foundations in the Netherlands Antilles including the Red Cross, International School, National Trust, Consular Corps, Rotary and Uniting for Children.